Myriad Genetics would be listed on the New York Stock Exchange under the ticker symbol “MGX”, and Myriad Pharmaceuticals will be listed on Nasdaq under the company’s current ticker symbol “MYGN.” Myriad has retained J.P. …
Investors found another reason to bid up shares of Myriad Genetics Inc. /quotes/zigman/58124 /quotes/nls/mygn MYGN, which is sole owner of ... hitting a fresh 52-week high. The stock surged last week on third-quarter results that …
Myriad Genetics Inc. (MYGN) recently announced its intention to present data from four clinical studies undertaken with Prolaris, at the 14th Annual Meeting of the Society for Urologic Oncology (:SUO) in Bethesda, MD. Additionally data …